IL-33 is able to promote the function of peripheral blood mononuclear cells (PBMCs), dendritic cells (DCs), CD8+ T cells and natural killer (NK) cells, which can in turn inhibit the tumor growth and metastasis (5). This evidence concerns the gene CD8A and neoplasm.